Inventor Showcase

Innovative Therapies for Macular Degeneration - Preserving Vision and Reducing Injections 

The global aging population is witnessing an alarming rise in the number of cases of eye disease, with retinal issues affecting the lives of over 250 million people worldwide. Patients with vision threatening conditions such as macular degeneration may receive injections in their eyes as often as every month to prevent blindness. While effective, maintaining these treatment regimens creates a huge burden for patients and their caregivers, as well as for healthcare providers. 

Join us on Wednesday, April 12 at noon to learn to learn how a team including an ocular biomaterials researcher, Katelyn E. Swindle-Reilly, Ph.D. and a vitreoretinal surgeon, Matthew Ohr, MD are developing technology to significantly reduce the treatment burden.  All are invited.